Zaburzenia depresyjne i lękowe a pandemia COVID-19 Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
gru 31, 2021
Słowa kluczowe:
zdrowie psychiczne, epidemiologia, PTSD, depresja, trauma, zaburzenia adaptacyjne
##plugins.themes.bootstrap3.article.main##
Abstrakt
Epidemia COVID-19 szybko stała się globalnym zagrożeniem zdrowotnym, dotyczącym nie tylko zdrowia fizycznego, ale też psychicznego, związanego z narażeniem populacji na niespodziewane ryzyko poważnej choroby i śmierci. Na przykład pracownicy medyczni, którzy mają kontakt z chorymi na COVID-19, nie tylko są narażeni na infekcję, lecz także mogą być świadkami zwiększonej liczby zachorowań, śmierci, jak również braków w zaopatrzeniu. Ponadto pacjenci hospitalizowani z powodu COVID-19 doświadczają izolacji społecznej, dyskomfortu fizycznego i lęku o przeżycie. Te doświadczenia zwiększają ryzyko rozwoju PTSD, co może być nasilane przez kolejne tygodnie po zachorowaniu, kiedy chorzy nie mają odpowiedniego wsparcia psychospołecznego. Poza tym wskaźniki zaburzeń depresyjnych i lękowych prawdopodobnie wzrastają, chociaż dane są niejednoznaczne.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Szulc , A. (2021). Zaburzenia depresyjne i lękowe a pandemia COVID-19 . Medycyna Faktów , 14(4(53), 356-363. https://doi.org/10.24292/01.MF.0421.4
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. UCE. Blisko co trzeci rodak w czasie pandemii skarży się na pogorszenie zdrowia psychicznego (access: 7.10.2021).
2. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020; 89: 531-42.
3. Sozzi M. Algeri L, Corsano M et al. Neuropsychology in the Times of COVID-19. The Role of the Psychologist in Taking Charge of Patients With Alterations of Cognitive Functions. Front Neurol. 2020; 11: 573207.
4. Alonso-Lana S, Marquie M, Ruiz A et al. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia. Front Aging Neurosci. 2020; 12: 588872.
5. Baker HA, Savafynia SA, Evered LA. The ‘third wave’: impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth. 2021; 126(1): 44e47.
6. Khademi M, Vaziri-Harami R, Shams J. Prevalence of Mental Health Problems and Its Associated Factors Among Recovered COVID-19 Patients During the Pandemic: A Single-Center Study. Front Psychiatry. 2021; 12: 602244.
7. Rogers JP, Chesney E, Oliver D et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020; 7(7): 611-27.
8. Taquet M, Geddes JR, Hussain M et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8: 416-27.
9. Sinanovic O, Muftic M, Sinanovic S. COVID-19 Pandemia: Neuropsychiatric Comorbidity and Consequences. Psychiatr Danub. 2020; 32(2): 236-44.
10. Mukaetova-Ladinska EB, Kronenberg G. Psychological and neuropsychiatric implications of COVID-19. Eur Arch Psychiatry Clin Neurosci. 2021; 271(2): 235-48.
11. Phiri P, Ramakrishnan R, Rathod S et al. An evaluation of the mental health impact of SARS-CoV-2 on patients, general public and healthcare professionals: A systematic review and meta-analysis. E Clinical Medicine. 2021; 34.
12. ICD-11 – Międzynarodowa Klasyfikacja Chorób. WHO 2019.
13. Kazlauskas E, Zelviene P, Lorenz L et al. A scoping review of ICD-11 adjustment disorder research. Eur J Psychotraumatol. 2018; 8: 1421819.
14. Cloitre M. ICD-11 complex post-traumatic stress disorder: simplifying diagnosis in trauma populations. Br J Psychiatry. 2020; 216: 129-31. http://doi.org/ 10.1192/bjp.2020.43.
15. O’Donnell ML, Alkemade N, Nickerson A et al. Impact of the diagnostic changes to post-traumatic stress disorder for DSM-5 and the proposed changes to ICD-11. Br J Psychiatry. 2014; 205: 230-5. http://doi.org/10.1192/bjp.bp.113.135285.
16. Maercker A, Brewin CR, Bryant RA et al. Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11. World Psychiatry. 2013; 12: 198-206.
17. Murphy S, Elklit A, Dokkedahl S et al. Testing competing factor models of the latent structure of post-traumatic stress disorder and complex post-traumatic stress disorder according to ICD-11. Eur J Psychotraumatol. 2018; 9: 1457393. http://doi.org/10.1080/20008198.2018.1457393.
18. Galecki P, Szulc A. Psychiatria. Edra Urban, Wrocław 2018.
19. Hamed MGM, Hagag RS. Med Hypotheses. The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients. Med Hypotheses. 2020; 144: 110140.
20. Samochowiec J, Dudek D, Kucharska-Mazur J et al. Leczenie farmakologiczne epizodu depresji i zaburzeń depresyjnych nawracających – wytyczne Polskiego Towarzystwa Psychiatrycznego i Konsultanta Krajowego ds. Psychiatrii Dorosłych. Psychiatr Pol. 2021; 55(2): 235-59.
21. Giannopoulou I, Galinaki S, Kollintza E et al. COVID-19 and post-traumatic stress disorder: The perfect ‘storm’ for mental health (Review). Exp Ther Med. 2021; 22: 1162.
22. Kyzar EJ, Purpura LJ, Shah J et al. Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up. Brain Behav Immun Health. 2021; 16: 100315. http://doi.org/10.1016/j.bbih.2021.100315.
2. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020; 89: 531-42.
3. Sozzi M. Algeri L, Corsano M et al. Neuropsychology in the Times of COVID-19. The Role of the Psychologist in Taking Charge of Patients With Alterations of Cognitive Functions. Front Neurol. 2020; 11: 573207.
4. Alonso-Lana S, Marquie M, Ruiz A et al. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia. Front Aging Neurosci. 2020; 12: 588872.
5. Baker HA, Savafynia SA, Evered LA. The ‘third wave’: impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth. 2021; 126(1): 44e47.
6. Khademi M, Vaziri-Harami R, Shams J. Prevalence of Mental Health Problems and Its Associated Factors Among Recovered COVID-19 Patients During the Pandemic: A Single-Center Study. Front Psychiatry. 2021; 12: 602244.
7. Rogers JP, Chesney E, Oliver D et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020; 7(7): 611-27.
8. Taquet M, Geddes JR, Hussain M et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8: 416-27.
9. Sinanovic O, Muftic M, Sinanovic S. COVID-19 Pandemia: Neuropsychiatric Comorbidity and Consequences. Psychiatr Danub. 2020; 32(2): 236-44.
10. Mukaetova-Ladinska EB, Kronenberg G. Psychological and neuropsychiatric implications of COVID-19. Eur Arch Psychiatry Clin Neurosci. 2021; 271(2): 235-48.
11. Phiri P, Ramakrishnan R, Rathod S et al. An evaluation of the mental health impact of SARS-CoV-2 on patients, general public and healthcare professionals: A systematic review and meta-analysis. E Clinical Medicine. 2021; 34.
12. ICD-11 – Międzynarodowa Klasyfikacja Chorób. WHO 2019.
13. Kazlauskas E, Zelviene P, Lorenz L et al. A scoping review of ICD-11 adjustment disorder research. Eur J Psychotraumatol. 2018; 8: 1421819.
14. Cloitre M. ICD-11 complex post-traumatic stress disorder: simplifying diagnosis in trauma populations. Br J Psychiatry. 2020; 216: 129-31. http://doi.org/ 10.1192/bjp.2020.43.
15. O’Donnell ML, Alkemade N, Nickerson A et al. Impact of the diagnostic changes to post-traumatic stress disorder for DSM-5 and the proposed changes to ICD-11. Br J Psychiatry. 2014; 205: 230-5. http://doi.org/10.1192/bjp.bp.113.135285.
16. Maercker A, Brewin CR, Bryant RA et al. Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11. World Psychiatry. 2013; 12: 198-206.
17. Murphy S, Elklit A, Dokkedahl S et al. Testing competing factor models of the latent structure of post-traumatic stress disorder and complex post-traumatic stress disorder according to ICD-11. Eur J Psychotraumatol. 2018; 9: 1457393. http://doi.org/10.1080/20008198.2018.1457393.
18. Galecki P, Szulc A. Psychiatria. Edra Urban, Wrocław 2018.
19. Hamed MGM, Hagag RS. Med Hypotheses. The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients. Med Hypotheses. 2020; 144: 110140.
20. Samochowiec J, Dudek D, Kucharska-Mazur J et al. Leczenie farmakologiczne epizodu depresji i zaburzeń depresyjnych nawracających – wytyczne Polskiego Towarzystwa Psychiatrycznego i Konsultanta Krajowego ds. Psychiatrii Dorosłych. Psychiatr Pol. 2021; 55(2): 235-59.
21. Giannopoulou I, Galinaki S, Kollintza E et al. COVID-19 and post-traumatic stress disorder: The perfect ‘storm’ for mental health (Review). Exp Ther Med. 2021; 22: 1162.
22. Kyzar EJ, Purpura LJ, Shah J et al. Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up. Brain Behav Immun Health. 2021; 16: 100315. http://doi.org/10.1016/j.bbih.2021.100315.